Madison Avenue Partners, LP 2seventy Bio, Inc. Transaction History
Madison Avenue Partners, LP
- $626 Million
- Q4 2024
A detailed history of Madison Avenue Partners, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 579,895 shares of TSVT stock, worth $1.51 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
579,895
Previous 2,563,222
77.38%
Holding current value
$1.51 Million
Previous $12.1 Million
85.92%
% of portfolio
0.27%
Previous 1.49%
Shares
8 transactions
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$15.5 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$9.78 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$9.52 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$7.59 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $98.5M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...